SCHEMBL10169728

SCHEMBL10169728

COc1ccccc1C(=O)Nc1ncc(S)s1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.61
NPC1 O15118 8/20 0.61
PKM P14618 2/20 0.58
PAX8 Q06710 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
ALDH1A1 P00352 6/20 0.56
SMN1; SMN2 Q16637 5/20 0.56
HPGD P15428 4/20 0.56
KDM4E B2RXH2 3/20 0.56
TDP1 Q9NUW8 1/20 0.56
MEN1 O00255 3/20 0.54
TP53 P04637 3/20 0.54
KMT2A Q03164 3/20 0.54
GAA P10253 2/20 0.54
RXFP1 Q9HBX9 1/20 0.53
MAPT P10636 3/20 0.53
HSD17B10 Q99714 4/20 0.52
TSHR P16473 3/20 0.52
LMNA P02545 2/20 0.52
MAPK1 P28482 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24074640 0.84 NPC1 (0.61) RAB9ANPC1PKMPAX8L3MBTL1
SCHEMBL10131745 0.84 NPC1 (0.53) RAB9ANPC1PKMPAX8L3MBTL1
SCHEMBL10132047 0.83 KMT2A (0.51) RAB9ANPC1PKMPAX8L3MBTL1
SCHEMBL10131508 0.82 ALDH1A1 (0.51) RAB9ANPC1PKMPAX8L3MBTL1
SCHEMBL13045038 0.82 RAB9A (0.58) RAB9ANPC1PKMPAX8L3MBTL1
SCHEMBL13907147 0.82 RAB9A (0.58) RAB9ANPC1PKMPAX8L3MBTL1
SCHEMBL5835976 0.82 CCNE1 (0.64) RAB9ANPC1PKMPAX8L3MBTL1
SCHEMBL4755933 0.81 RAB9A (0.57) RAB9ANPC1PKMPAX8L3MBTL1
SCHEMBL12994083 0.80 NPC1 (0.79) RAB9ANPC1PKMPAX8L3MBTL1
SCHEMBL4938035 0.80 ALDH1A1 (0.48) RAB9ANPC1PKMALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC RAB9A 1694/4885NPC1 585/4885PKM 3707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.